Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1233191.RA5Rb0SluPrY_vHsnXtR-i8HcjVP82oGBjhnawDz4fIKM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1233191.RA5Rb0SluPrY_vHsnXtR-i8HcjVP82oGBjhnawDz4fIKM130_assertion type Assertion NP1233191.RA5Rb0SluPrY_vHsnXtR-i8HcjVP82oGBjhnawDz4fIKM130_head.
- NP1233191.RA5Rb0SluPrY_vHsnXtR-i8HcjVP82oGBjhnawDz4fIKM130_assertion description "[This report has important clinical implications for the treatment of patients with neuroblastoma or other tumors that overexpress MYC(N) and harbor ALK mutations, such as non-small-cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233191.RA5Rb0SluPrY_vHsnXtR-i8HcjVP82oGBjhnawDz4fIKM130_provenance.
- NP1233191.RA5Rb0SluPrY_vHsnXtR-i8HcjVP82oGBjhnawDz4fIKM130_assertion evidence source_evidence_literature NP1233191.RA5Rb0SluPrY_vHsnXtR-i8HcjVP82oGBjhnawDz4fIKM130_provenance.
- NP1233191.RA5Rb0SluPrY_vHsnXtR-i8HcjVP82oGBjhnawDz4fIKM130_assertion SIO_000772 25351246 NP1233191.RA5Rb0SluPrY_vHsnXtR-i8HcjVP82oGBjhnawDz4fIKM130_provenance.
- NP1233191.RA5Rb0SluPrY_vHsnXtR-i8HcjVP82oGBjhnawDz4fIKM130_assertion wasDerivedFrom befree-2016 NP1233191.RA5Rb0SluPrY_vHsnXtR-i8HcjVP82oGBjhnawDz4fIKM130_provenance.
- NP1233191.RA5Rb0SluPrY_vHsnXtR-i8HcjVP82oGBjhnawDz4fIKM130_assertion wasGeneratedBy ECO_0000203 NP1233191.RA5Rb0SluPrY_vHsnXtR-i8HcjVP82oGBjhnawDz4fIKM130_provenance.